Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemoglobin

Showing results (151-160 of 3,216) with videos related to

Pageof 322
Sort By:
Hemoglobin|March 17, 2005
DNAase I hypersensitive site 3' to the beta-globin gene cluster containing two TAA insertions and a G-->A polymorphism is predominantly associated with the beta+-thalassemia IVS-I-6 (T-->C) mutationJuliana T N Martins, Silvana Bordin, Dulcinéia M de Albuquerque, et al.
Hemoglobin|January 1, 1992
International Hemoglobin Information Center variants list
Hemoglobin|March 11, 2004
Two new alpha chain variants: Hb Die [alpha93(FG5)Val --> Ala (alpha1)] and Hb Beziers [alpha99(G6)Lys --> Asn (alpha1)]Philippe Lacan, Martine Aubry, Nicole Couprie, et al.
Hemoglobin|November 19, 2021
Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of ImmigrationSulav D Atroshi, Nasir A S Al-Allawi, Adil A Eissa
Hemoglobin|November 24, 2021
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University HospitalSophia Delicou, Konstantina Aggeli, Konstantinos Magganas, et al.
Hemoglobin|January 1, 1987
Hemoglobin Alamo [alpha 2 beta 2(19)(B1)Asn----Asp] in a Venezuelan familyT Arends, O Castillo, G Garlín, et al.
Hemoglobin|January 1, 1987
Hb Olomouc or alpha 2 beta 2(86)(F2)Ala----Asp, a new high oxygen affinity variantK Indrak, B F Wiedermann, F Batek, et al.
Hemoglobin|September 7, 2022
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion TherapyKonstantinos Manganas, Sophia Delicou, Aikaterini Xydaki, et al.
Hemoglobin|May 24, 2011
1-(2-Hydroxyethoxy) methyl-2-methyl-3-hydroxyl-4-pyridinone: a targeted, bifunctional chelating agent for potential uranic detoxification in the kidneyGang Liu, Ping Men, Gerry H Kenner
Hemoglobin|January 1, 1989
The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemiaS K Ballas, C A Talacki, V M Rao, et al.
Pageof 322

Showing results (151-160 of 3,216) with videos related to

Sort By:
Pageof 322
Hemoglobin|March 17, 2005
DNAase I hypersensitive site 3' to the beta-globin gene cluster containing two TAA insertions and a G-->A polymorphism is predominantly associated with the beta+-thalassemia IVS-I-6 (T-->C) mutationJuliana T N Martins, Silvana Bordin, Dulcinéia M de Albuquerque, et al.
Hemoglobin|January 1, 1992
International Hemoglobin Information Center variants list
Hemoglobin|March 11, 2004
Two new alpha chain variants: Hb Die [alpha93(FG5)Val --> Ala (alpha1)] and Hb Beziers [alpha99(G6)Lys --> Asn (alpha1)]Philippe Lacan, Martine Aubry, Nicole Couprie, et al.
Hemoglobin|November 19, 2021
Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of ImmigrationSulav D Atroshi, Nasir A S Al-Allawi, Adil A Eissa
Hemoglobin|November 24, 2021
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University HospitalSophia Delicou, Konstantina Aggeli, Konstantinos Magganas, et al.
Hemoglobin|January 1, 1987
Hemoglobin Alamo [alpha 2 beta 2(19)(B1)Asn----Asp] in a Venezuelan familyT Arends, O Castillo, G Garlín, et al.
Hemoglobin|January 1, 1987
Hb Olomouc or alpha 2 beta 2(86)(F2)Ala----Asp, a new high oxygen affinity variantK Indrak, B F Wiedermann, F Batek, et al.
Hemoglobin|September 7, 2022
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion TherapyKonstantinos Manganas, Sophia Delicou, Aikaterini Xydaki, et al.
Hemoglobin|May 24, 2011
1-(2-Hydroxyethoxy) methyl-2-methyl-3-hydroxyl-4-pyridinone: a targeted, bifunctional chelating agent for potential uranic detoxification in the kidneyGang Liu, Ping Men, Gerry H Kenner
Hemoglobin|January 1, 1989
The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemiaS K Ballas, C A Talacki, V M Rao, et al.
Pageof 322